|Slideshows|September 17, 2018

A Rare Genetic Disorder That Causes Episodes of Flaccid Paralysis

About 30% of patients with periodic paralysis have unknown genetic mutation, making identification and treatment a challenge. Here: key points on genetics, testing, and subtypes of PPP.

A Rare Genetic Disorder That Causes Episodes of Flaccid Paralysis

Newsletter

Related Content

Key Considerations in Treatment of Spinal Muscular Atrophy / Considerações essenciais para o tratamento da atrofia muscular espinhal

Rare Diseases Awareness and Educational Needs / Conscientização sobre doenças raras e necessidades educacionais

Spinal Muscular Atrophy Resources for Clinicians and Families / Recursos sobre atrofia muscular espinhal para profissionais de saúde e familiares

Access to Clinical Trials for Spinal Muscular Atrophy in Brazil / Acesso a testes clínicos para atrofia muscular espinhal no Brasil

Challenges in Spinal Muscular Atrophy Monitoring, Management and Access to Care in Brazil / Desafios no monitoramento da atrofia muscular espinhal, manejo e acesso a atendimento de saúde no Brasil

Latest CME

4th Women in Neurology Conference

Medical Crossfire®: Integrating Real-World Data to Improve Outcomes for Patients With Multiple Sclerosis

Medical Crossfire® - Optimizing Management for Patients With Generalized Myasthenia Gravis: Focus on Complement Inhibitors

Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine

Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents

Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine

Evolving Perspectives in Alzheimer Disease : Reaching an Earlier Diagnosis, Understanding Neuroinflammation, and Exploring Therapeutic Advances

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings

Expert Illustrations & Commentaries™: Visualizing the Role of B Cells as Therapeutic Targets for Generalized Myasthenia Gravis

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

Patient, Provider, and Caregiver Connection™: Pediatric Myasthenia Gravis—Current Treatment and Emerging Concepts

Mind Moments™: Optimizing Management for Patients with Generalized Myasthenia Gravis

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

Identifying and Treating CIDP in the Modern Era

Cases and Conversations™: Little Voices, Big Challenges – Comprehensive Care for Pediatric Spinal Muscular Atrophy

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients

Patient, Provider, and Caregiver Connection: Improving Diagnosis and Care for Adolescent Myasthenia Gravis Patients – A New Frontier

A New Era in NMOSD Treatment: Optimizing Therapeutic Transitions and Reducing Patient Burden

PER Podcast™: Maximizing the Multidisciplinary Care Outcomes of Patients with Amyotrophic Lateral Sclerosis (ALS)

PER Podcast™: Best Strategies for Approaching the Diagnosis of Amyotrophic Lateral Sclerosis (ALS)

PER Postgame™: Updates from ANNA in the Management of IgA Nephropathy

Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Anti-MTBR Tau Antibody Etalanetug Given FDA Fast Track Designation

Smartphone-Based App for Muscular Relaxation Significantly Reduces Migraine-Related Disability in Emergency Room Settings

Early Intervention in Myasthenia Gravis

Earlier Initiation of Pimavanserin Leads to Better Improvement of Parkinson Disease Psychosis Symptoms

Incidence and Prevalence of Frontotemporal Dementia Similar to Dementia with Lewy Bodies, Meta-Analysis Shows